India's Natco Pharma gains after Q4 profit rise
** Shares of Natco Pharma NATP.NS rise 2.3% to 881.95 rupees ** Pharmaceuticals co's Q4 consol net profit rises 5.3% Y/Y to 4.07 bln rupees ($47.6 mln) ** Q4 revenue jumps 14.3% Y/Y, while expenses rose 23.5% ** Trading vols at 1.5 mln shares, 1.3x the 30-day average ** NATP down ~36% YTD ($1 = 85.4500 Indian rupees) (Reporting by Vijay Malkar) ((VijayDattaram.Malkar@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees